Clinical Trial Update: A Phase Ib/ Ⅱ Clinical Study of MIL62 in Primary Membranous Nephropathy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating MIL62 in primary membranous nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• MIL62

Snippet

Sponsor: Beijing Mabworks Biotech Co., Ltd. | Conditions: Primary Membranous Nephropathy | Phase 1, Phase 2 | Status: COMPLETED